Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biopharmaceutical company. The Company’s principal activities are research, drug development and clinical trials of psilocybin products. The Company offers healthcare professionals a variety serotonin-modulating medications by developing drug families derived from Psilocybin and MDMA. The Company is developing several prodrug families, beginning with a psilocybin-derived smoking cessation drug undergoing a NIDA-funded trial at Johns Hopkins University. It is also developing MYCO-006, short-acting chemical analogs derived from MDMA for treating various conditions, including anxiety and pain. It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by Losingmoneyon Oct 27, 2016 4:27pm

83 Views

Post# 25394946

RE:RE:No movement untill We

ezemoney wrote: People are all dreamy these days but just about every pot stock has sold off way way down from the highs. When support is broken....down she goes, that's how it works.
I wouldn't buy right now as this is the 3rd day in a row they have all sold off.

Perfect, maybe it's time you leave and don't come back because no one cares what you have to say?

Bullboard Posts

This junior mining stock offers billions in market exposure